These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 2581999)

  • 1. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
    Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
    Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
    Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
    N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
    Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
    N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual variation in the production and survival of F cells in sickle-cell disease.
    Dover GJ; Boyer SH; Charache S; Heintzelman K
    N Engl J Med; 1978 Dec; 299(26):1428-35. PubMed ID: 101847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
    Embury SH; Clark MR; Monroy G; Mohandas N
    J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type.
    Nagel RL; Fabry ME; Pagnier J; Zohoun I; Wajcman H; Baudin V; Labie D
    N Engl J Med; 1985 Apr; 312(14):880-4. PubMed ID: 2579336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
    Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
    J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-thalassemia changes the cell density profile in sickle cell anaemia.
    Tejuca M; Martinez G; Ferreira R; Hernández A; Ferrer L; Goicochea A; Hernández AC; Coyula R; Wade M; Colombo B
    Haematologia (Budap); 1989; 22(3):175-80. PubMed ID: 2583597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia.
    Honig GR; Gunay U; Mason RG; Vida LN; Ferenc C
    Pediatr Res; 1976 Jun; 10(6):613-20. PubMed ID: 1272638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Thalassemia and HbF concentration in sickle cell anemia.
    Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
    Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.
    Nagel RL; Steinberg MH
    Pediatr Pathol Mol Med; 2001; 20(2):123-36. PubMed ID: 12673837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
    Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
    Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monovalent cation changes in sickle erythrocytes: a direct reflection of alpha-globin gene number.
    Embury SH; Backer K; Glader BE
    J Lab Clin Med; 1985 Jul; 106(1):75-9. PubMed ID: 4009025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell syndromes. III. Silent-carrier alpha-thalassemia in combination with hemoglobin S and hemoglobin C.
    Honig GR; Mason RG; Tremaine LM; Vida LN
    Pediatr Res; 1979 Oct; 13(10):1109-11. PubMed ID: 503635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Ca(2+)-containing vesicles in sickle cell disorders.
    Westerman MP; Puchulu E; Schlegel RA; Salameh M; Williamson P
    J Lab Clin Med; 1994 Sep; 124(3):416-20. PubMed ID: 8083584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity.
    Powars DR; Meiselman HJ; Fisher TC; Hiti A; Johnson C
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):55-61. PubMed ID: 7508688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.